192 related articles for article (PubMed ID: 31526807)
1. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
Cheng T; Li J; Cheng Y; Zhang X; Qu Y
Exp Eye Res; 2019 Nov; 188():107805. PubMed ID: 31526807
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
3. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye.
Li J; Cheng T; Tian Q; Cheng Y; Zhao L; Zhang X; Qu Y
Drug Deliv; 2019 Dec; 26(1):188-198. PubMed ID: 30835587
[TBL] [Abstract][Full Text] [Related]
4. Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study.
Navarro-Partida J; Altamirano-Vallejo JC; Lopez-Naranjo EJ; Gonzalez-De la Rosa A; Manzano-Ramírez A; Apatiga-Castro LM; Armendáriz-Borunda J; Santos A
J Ocul Pharmacol Ther; 2020; 36(6):393-403. PubMed ID: 32564664
[No Abstract] [Full Text] [Related]
5. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
7. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Del Priore LV; Weissman H; Schiff WM; Ober MD
Retina; 2005; 25(7):851-5. PubMed ID: 16205563
[TBL] [Abstract][Full Text] [Related]
11. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study.
Ip M; Kahana A; Altaweel M
Semin Ophthalmol; 2003 Jun; 18(2):67-73. PubMed ID: 14566625
[TBL] [Abstract][Full Text] [Related]
12. Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
Yoo SG; Kim JH; Lee TG; Kim CG; Kim JW
Indian J Ophthalmol; 2015 Jan; 63(1):25-9. PubMed ID: 25686058
[TBL] [Abstract][Full Text] [Related]
13. Different dosages of intravitreal triamcinolone acetonide injections for macular edema secondary to central retinal vein occlusion.
Wei Y; Wang H; Chen F; Zu Z; Bi C; Yang X
Eye Sci; 2012 Sep; 27(3):152-7. PubMed ID: 22993062
[TBL] [Abstract][Full Text] [Related]
14. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
Wu WC; Cheng KC; Wu HJ
Eye (Lond); 2009 Dec; 23(12):2215-22. PubMed ID: 19218991
[TBL] [Abstract][Full Text] [Related]
16. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion.
Batioglu F; Ozmert E; Akmese E
Ann Ophthalmol (Skokie); 2007; 39(4):307-12. PubMed ID: 18025651
[TBL] [Abstract][Full Text] [Related]
17. Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment.
Zhang K; Chen Y; Sun X; Zhong Q; Lin L; Gao Y; Hong F
Medicine (Baltimore); 2018 Sep; 97(39):e12464. PubMed ID: 30278530
[TBL] [Abstract][Full Text] [Related]
18. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
20. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]